Abstract Treatment-resistant schizophrenia (TRS) affects up to 30% of individuals with schizophrenia who fail to respond to standard antipsychotics. This…
Abstract Background/Objective: Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting adverse effect of various chemotherapeutic agents. Previous work demonstrated that…
Abstract Background: Cancer cachexia has substantial impacts on people’s quality of life. There is no current gold standard treatment, but…
Abstract Chronic non-cancer pain, defined by the Center for Disease Control and Prevention (CDC) as lasting beyond three months, significantly…
Abstract This comprehensive review examines the complex relationship between sleep disorders and rheumatic diseases, supported by findings from the latest…
Abstract Cannabidiol exerts also clinical beneficial non-seizure outocomes. Cannabidiol should be considered in other developmental epileptic encephalopathies. Cannabidiol presents antiepileptic,…
Abstract The use of patient‐reported outcomes (PROMs) of quality of life (QOL) is common in cachexia trials. Patients’ self‐report on…
Abstract Simple Summary: It is easy to find success stories on the internet of patients with cancer who seem to…
Abstract Quality of life (QoL) is essential for maintaining a healthy, balanced lifestyle, especially among individuals with chronic diseases. Saudi…
Abstract Background: Opioids have been commonly used to treat chronic pain, but they are associated with significant morbidity and mortality.…